Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity.

MLA

Orioli, Laura, et al. “Circulating Myostatin as a Biomarker of Muscle Mass and Strength in Individuals with Cancer or Obesity.” Clinical Nutrition (Edinburgh, Scotland), vol. 43, no. 7, July 2024, pp. 1800–08. EBSCOhost, https://doi.org/10.1016/j.clnu.2024.05.046.

APA

Orioli, L., Samaras, S., Sawadogo, K., de Barsy, M., Lause, P., Deswysen, Y., Navez, B., Thissen, J.-P., & Loumaye, A. (2024). Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity. Clinical Nutrition (Edinburgh, Scotland), 43(7), 1800–1808. https://doi.org/10.1016/j.clnu.2024.05.046

Chicago

Orioli, Laura, Sofia Samaras, Kiswendsida Sawadogo, Marie de Barsy, Pascale Lause, Yannick Deswysen, Benoit Navez, Jean-Paul Thissen, and Audrey Loumaye. 2024. “Circulating Myostatin as a Biomarker of Muscle Mass and Strength in Individuals with Cancer or Obesity.” Clinical Nutrition (Edinburgh, Scotland) 43 (7): 1800–1808. doi:10.1016/j.clnu.2024.05.046.